Laurus Labs

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE947Q01028
  • NSEID: LAURUSLABS
  • BSEID: 540222
INR
1,026.00
13.35 (1.32%)
BSENSE

Dec 05

BSE+NSE Vol: 9.55 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Glenmark Pharma
Laurus Labs
Aurobindo Pharma
Alkem Lab
Ipca Labs
Biocon
Abbott India
Ajanta Pharma
Mankind Pharma
Glaxosmi. Pharma
Anthem Bioscienc
Why is Laurus Labs Ltd ?
1
High Management Efficiency with a high ROCE of 16.75%
2
With a growth in Net Profit of 993.4%, the company declared Very Positive results in Sep 25
  • The company has declared positive results for the last 4 consecutive quarters
  • PBT LESS OI(Q) At Rs 242.77 cr has Grown at 1233.17%
  • PAT(Q) At Rs 194.97 cr has Grown at 882.7%
  • OPERATING PROFIT TO INTEREST(Q) Highest at 10.08 times
3
High Institutional Holdings at 37.63%
  • These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
4
Market Beating performance in long term as well as near term
  • Along with generating 74.45% returns in the last 1 year, the stock has outperformed BSE500 in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report
Verdict Report
How much should you buy?
  1. Overall Portfolio exposure to Laurus Labs should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Laurus Labs for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Laurus Labs
74.45%
2.11
35.26%
Sensex
4.83%
0.41
11.83%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
11.55%
EBIT Growth (5y)
5.37%
EBIT to Interest (avg)
7.46
Debt to EBITDA (avg)
1.89
Net Debt to Equity (avg)
0.45
Sales to Capital Employed (avg)
0.92
Tax Ratio
27.50%
Dividend Payout Ratio
26.86%
Pledged Shares
2.69%
Institutional Holding
37.63%
ROCE (avg)
17.62%
ROE (avg)
16.67%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
81
Industry P/E
34
Price to Book Value
11.53
EV to EBIT
55.47
EV to EBITDA
38.59
EV to Capital Employed
8.27
EV to Sales
9.05
PEG Ratio
0.19
Dividend Yield
0.16%
ROCE (Latest)
14.92%
ROE (Latest)
14.23%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Bullish
Bullish
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

23What is working for the Company
PBT LESS OI(Q)

At Rs 242.77 cr has Grown at 1233.17%

PAT(Q)

At Rs 194.97 cr has Grown at 882.7%

OPERATING PROFIT TO INTEREST(Q)

Highest at 10.08 times

NET SALES(Q)

At Rs 1,653.47 cr has Grown at 35.12%

-1What is not working for the Company
DEBT-EQUITY RATIO(HY)

Highest at 3.49 times

Loading Valuation Snapshot...
Here's what is working for Laurus Labs
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 242.77 cr has Grown at 1233.17%
Year on Year (YoY)
MOJO Watch
Near term PBT trend is very positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 194.97 cr has Grown at 882.7%
Year on Year (YoY)
MOJO Watch
Near term PAT trend is very positive

PAT (Rs Cr)

Operating Profit to Interest - Quarterly
Highest at 10.08 times
in the last five quarters
MOJO Watch
The company's ability to manage interest payments is improving

Operating Profit to Interest

Net Sales - Quarterly
At Rs 1,653.47 cr has Grown at 35.12%
Year on Year (YoY)
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Here's what is not working for Laurus Labs
Debt-Equity Ratio - Half Yearly
Highest at 3.49 times
in the last five half yearly periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio